Literature DB >> 19052094

Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.

Shufeng Liu1, Wei Yang, Le Shen, Jerrold R Turner, Carolyn B Coyne, Tianyi Wang.   

Abstract

A tight junction (TJ) protein, claudin-1 (CLDN1), was identified recently as a key factor for hepatitis C virus (HCV) entry. Here, we show that another TJ protein, occludin, is also required for HCV entry. Mutational study of CLDN1 revealed that its tight junctional distribution plays an important role in mediating viral entry. Together, these data support the model in which HCV enters liver cells from the TJ. Interestingly, HCV infection of Huh-7 hepatoma cells downregulated the expression of CLDN1 and occludin, preventing superinfection. The altered TJ protein expression may contribute to the morphological and functional changes observed in HCV-infected hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052094      PMCID: PMC2643775          DOI: 10.1128/JVI.01888-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Dynamin II interacts with the cadherin- and occludin-based protein complexes at the blood-testis barrier in adult rat testes.

Authors:  Pearl P Y Lie; Weiliang Xia; Claire Q F Wang; Dolores D Mruk; Helen H N Yan; Ching-hang Wong; Will M Lee; C Yan Cheng
Journal:  J Endocrinol       Date:  2006-12       Impact factor: 4.286

Review 2.  Molecular pathogenesis of cholestasis.

Authors:  M Trauner; P J Meier; J L Boyer
Journal:  N Engl J Med       Date:  1998-10-22       Impact factor: 91.245

3.  Hepatitis C virus entry depends on clathrin-mediated endocytosis.

Authors:  Emmanuelle Blanchard; Sandrine Belouzard; Lucie Goueslain; Takaji Wakita; Jean Dubuisson; Czeslaw Wychowski; Yves Rouillé
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation.

Authors:  Kazuaki Umeda; Junichi Ikenouchi; Sayaka Katahira-Tayama; Kyoko Furuse; Hiroyuki Sasaki; Mayumi Nakayama; Takeshi Matsui; Sachiko Tsukita; Mikio Furuse; Shoichiro Tsukita
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

5.  Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease.

Authors:  Smail Hadj-Rabia; Lekbir Baala; Pierre Vabres; Dominique Hamel-Teillac; Emmanuel Jacquemin; Monique Fabre; Stanislas Lyonnet; Yves De Prost; Arnold Munnich; Michelle Hadchouel; Asma Smahi
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Effect of cell polarization on hepatitis C virus entry.

Authors:  Christopher J Mee; Joe Grove; Helen J Harris; Ke Hu; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

7.  CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.

Authors:  Michela Brazzoli; Alessia Bianchi; Sara Filippini; Amy Weiner; Qing Zhu; Mariagrazia Pizza; Stefania Crotta
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

8.  Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus.

Authors:  Rodney S Russell; Jean-Christophe Meunier; Shingo Takikawa; Kristina Faulk; Ronald E Engle; Jens Bukh; Robert H Purcell; Suzanne U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

9.  Hepatitis C virus receptor expression in normal and diseased liver tissue.

Authors:  Gary M Reynolds; Helen J Harris; Adam Jennings; Ke Hu; Joe Grove; Patricia F Lalor; David H Adams; Peter Balfe; Stefan G Hübscher; Jane A McKeating
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

10.  Induction of mutant dynamin specifically blocks endocytic coated vesicle formation.

Authors:  H Damke; T Baba; D E Warnock; S L Schmid
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more
  156 in total

1.  Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus.

Authors:  Fumi Kobayashi; Shuhei Yamada; Shuhei Taguwa; Chikako Kataoka; Satomi Naito; Yoshiki Hama; Hideki Tani; Yoshiharu Matsuura; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

2.  Impact of intra- and interspecies variation of occludin on its function as coreceptor for authentic hepatitis C virus particles.

Authors:  Sandra Ciesek; Sandra Westhaus; Melanie Wicht; Ilka Wappler; Sylvana Henschen; Christoph Sarrazin; Nabila Hamdi; Ahmed I Abdelaziz; Christian P Strassburg; Heiner Wedemeyer; Michael P Manns; Thomas Pietschmann; Thomas von Hahn
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

3.  A human claudin-1-derived peptide inhibits hepatitis C virus entry.

Authors:  Youhui Si; Shufeng Liu; Xiuying Liu; Jana L Jacobs; Min Cheng; Yuqiang Niu; Qi Jin; Tianyi Wang; Wei Yang
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425

4.  Study of hepatitis C virus entry in genetically humanized mice.

Authors:  Marcus Dorner; Charles M Rice; Alexander Ploss
Journal:  Methods       Date:  2012-06-08       Impact factor: 3.608

Review 5.  Tight junctions in the testis: new perspectives.

Authors:  Dolores D Mruk; C Y Cheng
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

6.  Hepatitis C virus core protein activates autophagy through EIF2AK3 and ATF6 UPR pathway-mediated MAP1LC3B and ATG12 expression.

Authors:  Ji Wang; Rongyan Kang; He Huang; Xueyan Xi; Bei Wang; Jianwei Wang; Zhendong Zhao
Journal:  Autophagy       Date:  2014-02-20       Impact factor: 16.016

Review 7.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

8.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

9.  Transient activation of the PI3K-AKT pathway by hepatitis C virus to enhance viral entry.

Authors:  Zhe Liu; Yongjun Tian; Keigo Machida; Michael M C Lai; Guangxiang Luo; Steven K H Foung; Jing-hsiung James Ou
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

10.  Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.

Authors:  Naina Barretto; Bruno Sainz; Snawar Hussain; Susan L Uprichard
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.